Hanways Chempharm

Hanways Chempharm is a specialized pharmaceutical company headquartered in Wuhan, China, focused on the research, development, and distribution of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and fine chemicals. Established in 2009, the company has evolved from a trading entity into a comprehensive solutions provider, offering custom synthesis and manufacturing (CDMO/CMO) services to global markets. Its diverse product portfolio includes high-purity immunosuppressants, oncology agents, and gastroenterology treatments, featuring compounds like Tacrolimus, Paclitaxel, and Ursodeoxycholic acid. Hanways maintains a strong presence in international trade fairs such as CPhI, serving clients across North America, Europe, and Southeast Asia.